Moderna’s COVID-19 Vaccine Effective in Toddlers, Babies: FDA

Click here to read the full article.

Moderna’s COVID-19 vaccine is effective for children as young as 6 months old, Food and Drug Administration (FDA) scientists said in a new analysis published late June 11.

“Available data support the effectiveness of the Moderna COVID-19 Vaccine in preventing symptomatic COVID-19 in pediatric age groups from 6 months through 17 years of age,” the scientists said in the document (pdf).

The analysis was filed ahead of the agency’s meeting with advisers with regards to requests for emergency clearance from Moderna and Pfizer for their COVID-19 vaccines for children as young as 6 months old. Moderna is also seeking clearance for other adolescents, while Pfizer’s shot is already available to children aged 5 and older.

The analysis was based on results from clinical trials funded by Moderna.

Continue reading here.

Scroll down for comments and share your thoughts!

What do you think?

Leave a Reply

Your email address will not be published.

GIPHY App Key not set. Please check settings

Justin Bieber suffers paralysis on right side of face

NFL coach fined $100,000 for comparing Jan 6 to BLM riots